DENTSPLY SIRONA Inc.
XRAYHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeDENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. Valued at $2.19B, XRAY is a mid-cap name in its sector. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
Market Cap
$2.19B
Beta
0.85
P/E (TTM)
—
P/E (Fwd)
7.24
EPS (TTM)
$-2.73
EPS (Fwd)
$1.52
ROE
-33.0%
ROA
2.0%
Cash
$239.0M
Total Debt
$2.33B
Free CF
$141.6M
52W Change
-16.9%
Annual Financials
Cash vs Debt
Where XRAY stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, XRAY finished 4.16% below its 150-day moving average ($11.78) and 3.50% below its 200-day moving average ($11.70). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is XRAY overbought or oversold?
At the September 3, 2026 close, XRAY's RSI(14) was 43.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $239.0M in cash, though total debt stands at $2.33B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $141.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -33.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $3.92B (2022) to $3.68B (2025).
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence DENTSPLY SIRONA Inc.'s trajectory.